HITK Hi-Tech Pharmacal Co., Inc. featured news, full reports, and detailed charts
Hi-Tech Pharmacal Co., Inc. (HITK) Wrap Up:
Hi-Tech Pharmacal Co., Inc. (“Hi-Tech” or the “Company”, which may be referred to as “we”, “us” or “our”), a Delaware corporation, incorporated in April 1982, is a growing specialty manufacturer and marketer of prescription, over-the-counter and nutritional products. We develop, manufacture and market products in three categories – generics, over the counter (OTC) brands and prescription brands. We produce a wide range of products for various disease states, including asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, oral care, neurological disorders and other conditions. Most of our generic products are prescription items and include oral solutions and suspensions, as well as topical creams and ointments. We also specialize in the manufacture of products in our state of the art sterile facility capable of producing liquid ophthalmic, otic and inhalation products. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2007%2f07%2f16%2f0001193125-07-155091.html#FIS_BUSINESS"www.hitechpharm.com
366 Employees
Founded in 1982
Hi Tech Pharmacal Co. Inc. (HITK:NASDAQ)
LAST $19.52 USD
CHANGE TODAY +0.26 1.35%
VOLUME 281.3K
As of 4:00 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).
Snapshot of Hi Tech Pharmacal Co. Inc. (HITK)
|
OPEN
$19.11
|
PREVIOUS CLOSE
$19.26
|
|
|
DAY HIGH
$19.66
|
DAY LOW
$19.07
|
|
|
52 WEEK HIGH
10/20/09 - $25.60
|
52 WEEK LOW
12/4/08 - $3.46
|
|
|
MARKET CAP
231.0M
|
AVERAGE VOLUME 3 mo
155.1K
|
|
|
DILUTED EPS TTM
$1.46
|
SHARES OUTSTANDING
11.8M
|
|
|
HITK Does Not Pay Dividends
|
P/E TTM
13.4x
|
|
| K = Thousands M = Millions B = Billions | ||
HITK Top Compensated Officers
Mr. David S. Seltzer
Chairman, Chief Executive Officer, President,...
Age: 49
Total Annual Compensation: $442.0K
Mr. William Peters
Chief Financial Officer and Vice President of...
Age: 41
Total Annual Compensation: $296.0K
Mr. Bryce M. Harvey
President of Midlothian Laboritories
Age: 53
Total Annual Compensation: $376.0K
Mr. Gary M. April
President of Health Care Products Division an...
Age: 52
Total Annual Compensation: $223.0K
Mr. Davis S. Caskey
Vice President of Pharmaceutical Operations -...
Age: 61
Total Annual Compensation: $27.0K
Executives, Board Directors
Compensation as of Fiscal Year 2009.
Key developments for Hi Tech Pharmacal Co. Inc. (HITK)
Hi Tech Pharmacal Co. Inc. - Conference Presentation Call
10/30/2009
Hi Tech Pharmacal Co. Inc. - Conference Presentation Calls
Hi Tech Pharmacal Co. Inc., Annual General Meeting, Nov 12, 2009
10/1/2009
Hi Tech Pharmacal Co. Inc., Annual General Meeting, Nov 12, 2009, at 10:00 US Eastern Time. Location: 10 Edison Street, Amityville, NY 11701, United States. Agenda: To elect Messrs. David S. Seltzer, Reuben Seltzer, Martin M. Goldwyn, Yashar Hirshaut, M.D., Bruce W. Simpson, Anthony J. Puglisi and Jack van Hulst to the Board of Directors, each to serve for a term to expire at the 2010 Annual Meeting; to adopt the company's 2009 stock option plan for a fifteen year term and authorize 500,000 shares of common stock reserved for issuance thereunder; to ratify the appointment of Eisner LLP as the company's independent auditors for the fiscal year ending April 30, 2010; and to transact such other business as may properly come before the meeting or any adjournment thereof.
Hi Tech Pharmacal Co. Inc. expected to Report Q2 2010 Results on December 7, 2009. This event was calculated by Capital IQ (Created on September 11, 2009).
09/11/2009
Hi Tech Pharmacal Co. Inc. expected to Report Q2 2010 Results on December 7, 2009. This event was calculated by Capital IQ (Created on September 11, 2009).
HITK Competitors
| Company | Last | Change |
| Genomic Health Inc | $19.29 USD | +0.25 |
| Lannett Co Inc | $6.40 USD | +1.45 |
| Quidel Corp | $13.23 USD | -0.04 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | HITK | Industry Range |
| Price/Earnings | 13.2x |
|
| Price/Sales | 1.6x |
|
| Price/Book | 2.3x |
|
| Price/Cash Flow | 13.4x |
|
| TEV/Sales | 1.5x |
|
|
HITK |
||
|
HITK transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Hi-Tech Pharmacal Co., Inc.
More news for HITK
Earnings roundup: Hi-Tech Pharmacal, John Wiley
Copyright © 2009 Yahoo! All rights reserved. Privacy Policy - Terms of Service - Copyright Policy - Report Problems Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quote data delayed 15 minutes for Nasdaq, NYSE and Amex. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Yahoo! is not an investment adviser and does not provide, endorse or review any information or data contained herein....Click here to read the whole Article (external link)
Stocks Close Ahead for Fourth Straight Day
After starting the month on a sour note, the market has traded higher for four straight September sessions. In what is typically a rocky month for the stock market it appears that the bulls are still in charge, though the near-term outlook for equities remains shaky. The Cosmetic Laser Stocks Index was the top performing tickerspy Index on the day, led by Candela Corp (Nasdaq: CLZR - News) with a 43% gain.Stocks climbed for the 4th straight day, led by the Nasdaq, which rose 23 points, or 1.1%, to 2,060. The S&P added 8 points to 1,033, while the Dow climbed 50 points to 9,547 points. Oil edged up 21 cents to $71.31 a barrel, while gold slipped -$2.70 to $997.10 an ounce. On the economic front, the release of the Fed's Beige Book indicated that all but one of the Fed's 12 regions saw economic conditions stabilize, with the one exeption being St Louis, which saw the pace of economic decline moderating. Overall most of the Fed Regions were "cautiously positive" on the economy's outlook. In earnings news, shares of Pep Boys (NYSE: PBY - ...Click here to read the whole Article (external link)
HI TECH PHARMACAL CO INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
Show all filings for HI TECH PHARMACAL CO INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for HI TECH PHARMACAL CO INC 9-Sep-2009Results of Operations and Financial Condition, Financial Statements and Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information pro...Click here to read the whole Article (external link)
HI TECH PHARMACAL CO INC Financials
PERIOD ENDING31-Jul-0930-Apr-0931-Jan-0931-Oct-08Total Revenue43,477 38,315 29,420 25,124 Cost of Revenue16,927 18,401 15,604 13,131 Gross Profit26,550 19,914 13,816 11,993 Operating ExpensesResearch Development1,385 1,950 1,790 1,844 Selling General and Administrative12,699 10,633 9,261 7,466 Non Recurring(387)273 (159)(114)Others - - - - Total Operating Expenses - - - - Operating Income or Loss12,853 7,058 2,924 2,797 Income from Continuing OperationsTotal Other Income/Expenses Net1,001 694 548 86 Earnings Before Interest And Taxes13,854 7,752 3,472 2,883 Interest Expense - 9 12 13 Income Before Tax13,854 7,743 3,460 2,870 Income Tax Expense5,180 2,621 1,389 1,746 Minority Interest - - - - Net Income From Continuing Ops8,674 5,122 2,071 1,124 Non-recurring EventsDiscontinued Operations - - - - Extraordinary Items - - - - Effect Of Accounting Changes - ...Click here to read the whole Article (external link)
Hi-Tech Pharmacal, Contango Oil: Ratings Changes
Stock quotes in this article: HITK , MCF , MCS , ...Click here to read the whole Article (external link)
Hi-Tech Pharmacal to Present at the 20th Annual Oppenheimer Healthcare Conference
AMITYVILLE, N.Y.--(BUSINESS WIRE)--Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK - Newsth Annual Oppenheimer Healthcare Conference. David Seltzer, President and Chief Executive Officer, will deliver the Company's presentation on Tuesday, November 3, 2009, at 3:55 p.m. Eastern Time. The conference is being held November 3-4, 2009, at the Waldorf Astoria Hotel, New York, New York. A live audio webcast of the Company's presentation can be accessed on the Company’s website:http://www.hitechpharm.com.The webcast will be archived within 24 hours after the live event and will be available for 90 days.About Hi-Tech PharmacalHi-Tech Pharmacal is a specialty pharmaceutical company developing, manufacturing and marketing generic and branded products. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic, otic and inhalation products. The Company’s Health Care Products Division is a leading developer and marketer of branded prescription and OTC prod...Click here to read the whole Article (external link)
Would you like to leave a comment about Hi-Tech Pharmacal Co., Inc. HITK
Find out what social network information about Hi-Tech Pharmacal Co., Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Hi-Tech Pharmacal Co., Inc. there is more great information available at Realpennies.com